Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net loss	$ (12,187,830)	$ (2,844,230)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	7,897	31,472
Amortization of debt discount	52,662	68,392
Non-cash lease expense	104,463	127,708
Stock based compensation	2,079,159	745,620
Change in assets and liabilities:
Accounts receivable	8,873,974	3,301,954
Prepaid and other current assets	(953,736)	553,802
Accounts payable and accrued expenses	2,074,567	613,873
Accrued salaries and wages	454,910	(332,875)
Lease liabilities	(98,812)	(129,196)
Royalty payable	(2,493,892)	(928,583)
Deferred revenue	(16,618)	504,559
Net cash (used in) provided by operating activities	(2,103,256)	1,712,496
Cash flows from investing activities
Maturity (purchase) of marketable securities	12,514,661
Maturity (purchase) of marketable securities		(15,108,782)
Net cash (used in) provided by investing activities	12,514,661	(15,108,782)
Cash flows provided by financing activities
Proceeds from stock option exercises	91,634	579,619
Return of profit	5,824	0
Net cash provided by financing activities	97,458	579,619
Effect of foreign currency translation on cash	(37,366)	14,894
Net increase (decrease) in cash and cash equivalents	10,471,497	(12,801,773)
Cash and cash equivalents, beginning of period	37,853,947	48,251,336
Cash and cash equivalents, end of period	48,325,444	35,449,563
Interest paid during the period	414,963	114,521
Supplemental disclosure of non-cash finance transactions
Common stock issued for debt conversion	2,571,200	0
Debt issuance cost associated with debt conversion	109,399	0
Issuance of restricted stock	$ 32	$ 6